These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 1603215)
1. Human monoclonal antibodies in sepsis. de Koning J; Westendorp RG Neth J Med; 1992 Apr; 40(3-4):215. PubMed ID: 1603215 [No Abstract] [Full Text] [Related]
2. Antibody to endotoxin in the treatment of gram-negative sepsis. McCabe WR JAMA; 1992 May; 267(17):2325; author reply 2326. PubMed ID: 1564763 [No Abstract] [Full Text] [Related]
3. Antibody to endotoxin in the treatment of gram-negative sepsis. van Deventer S JAMA; 1992 May; 267(17):2325-6. PubMed ID: 1564765 [No Abstract] [Full Text] [Related]
9. Anti-endotoxin monoclonal antibodies--a second look. Wenzel RP N Engl J Med; 1992 Apr; 326(17):1151-3. PubMed ID: 1552918 [No Abstract] [Full Text] [Related]
10. [Introduction of immunotherapeutic agents in clinical practice; current status concerning anti-endotoxin antibody HA-1A in the control of sepsis]. van Deventer SJ; van der Linden CJ; Roord JJ; Schellekens H; Schellekens JF Ned Tijdschr Geneeskd; 1993 Feb; 137(7):334-6. PubMed ID: 8437630 [No Abstract] [Full Text] [Related]
11. Antiendotoxin antibodies: a dead end? Cross AS Ann Intern Med; 1994 Jul; 121(1):58-60. PubMed ID: 8198349 [No Abstract] [Full Text] [Related]
13. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock. Calandra T; Baumgartner JD; Glauser MP Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424 [TBL] [Abstract][Full Text] [Related]
14. [Cytokines and septic shock. New perspectives on its treatment]. Zamora Madaria E An Med Interna; 1993 Dec; 10(12):573-5. PubMed ID: 8049320 [No Abstract] [Full Text] [Related]
15. HA-1A. A human monoclonal antibody for the treatment of gram-negative sepsis. Smith CR; Straube RC; Ziegler EJ Infect Dis Clin North Am; 1992 Mar; 6(1):253-66. PubMed ID: 1578120 [TBL] [Abstract][Full Text] [Related]
16. [The use of monoclonal antibodies to lipid A for the correction of the hemodynamic disorders in endotoxemia]. Rumiantsev AG; Kasatkin VN; Blokhin BM; Golubykh VL; Borovikov DV; Vlasik TN; Kanaeva ES; Kalantarov GF Gematol Transfuziol; 1993 Jan; 38(1):31-3. PubMed ID: 8020702 [TBL] [Abstract][Full Text] [Related]
17. Human monoclonal antibody against endotoxin. Zarowitz BJ DICP; 1991; 25(7-8):778-83. PubMed ID: 1949939 [TBL] [Abstract][Full Text] [Related]
18. Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group. McCloskey RV; Straube RC; Sanders C; Smith SM; Smith CR Ann Intern Med; 1994 Jul; 121(1):1-5. PubMed ID: 8198341 [TBL] [Abstract][Full Text] [Related]
19. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies. Barriere SL; Guglielmo BJ Clin Pharm; 1992 Mar; 11(3):223-35. PubMed ID: 1611812 [TBL] [Abstract][Full Text] [Related]
20. Adoptive immunotherapy of gram-negative sepsis: use of monoclonal antibodies to lipopolysaccharide. Fink MP Crit Care Med; 1993 Feb; 21(2 Suppl):S32-9. PubMed ID: 8428494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]